Curated News
By: NewsRamp Editorial Staff
August 04, 2025
EVERMIND Expands with $4M Acquisition of Cognitive Health Beverage Platform
TLDR
- BitFrontier Capital Holdings acquires ERApeutics, LLC, enhancing its portfolio with EVERMIND™, a cognitive health beverage, positioning for growth and institutional investment.
- The acquisition involves a $4,000,000 equity deal, issuing 400,000,000 shares at $0.01 each, strengthening BFCH's balance sheet and supporting its OTCQB uplisting strategy.
- EVERMIND™ aims to improve mental clarity and cognitive performance, contributing to a healthier society with its science-backed, plant-based functional beverage.
- Discover EVERMIND™, a revolutionary cognitive health beverage, as BFCH expands into the wellness sector with a unique, IP-backed product ready for the market.
Impact - Why it Matters
This acquisition is a game-changer for EVERMIND and the cognitive health beverage market. It not only introduces a scientifically backed, ready-to-market product that addresses the growing consumer demand for functional beverages but also positions EVERMIND as a serious contender in the wellness and performance sectors. For investors and consumers alike, this move signals EVERMIND's commitment to innovation and growth in the competitive landscape of health-focused beverages, offering new opportunities for investment and access to products designed to enhance mental clarity and cognitive performance.
Summary
BitFrontier Capital Holdings, Inc., operating as EVERMIND Holdings, Inc., has announced a significant move by signing a binding Letter of Intent to acquire ERApeutics, LLC, the developer of the EVERMIND™ functional beverage platform aimed at enhancing cognitive health. This acquisition, valued at $4,000,000 through the issuance of 400,000,000 restricted common shares at $0.01 per share, not only adds a promising IP-backed consumer brand to EVERMIND's portfolio but also strengthens its balance sheet. EVERMIND™, a physician-formulated, plant-based protein shake, is designed to offer both immediate and long-term brain health benefits, with a commercialization-ready status and a comprehensive asset package including proprietary formulations, e-commerce infrastructure, and a pipeline of future products.
The deal underscores EVERMIND's strategic focus on human optimization and cognitive performance, aligning with its broader goals of uplisting to the OTCQB and engaging institutional capital. With the functional beverage market gaining traction among major players like Keurig Dr Pepper and Coca-Cola, EVERMIND™ positions BFCH to capitalize on this trend with its unique brain-first platform. The acquisition is expected to close within 60 to 90 days, marking a pivotal step in BFCH's transition from a legacy status to a growth-oriented platform.
Source Statement
This curated news summary relied on content disributed by NewMediaWire. Read the original source here, EVERMIND Expands with $4M Acquisition of Cognitive Health Beverage Platform
